Telostop Plus Tablet 80/10/10 mg
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
MFDS item code 201801976 · Approved 2018.05.10
Treatment of hypertension, improvement of dyslipidemia, inhibition of atherosclerosis, and prevention of cardiovascular disease
This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled even with the administration of a combination of telmisartan and amlodipine. Additionally, rosuvastatin is used as an adjunct for patients with primary hypercholesterolemia and mixed hyperlipidemia who find it difficult to control their condition with diet and exercise. It helps improve lipids in patients with homozygous familial hypercholesterolemia or dysbetalipoproteinemia and lowers total cholesterol and LDL cholesterol, delaying the progression of atherosclerosis. Furthermore, it is used in high-risk patients with a high risk of cardiovascular disease to reduce the risk of stroke, myocardial infarction, and arterial revascularization procedures. This medication improves overall cardiovascular health through the management of hypertension and hyperlipidemia.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take it at the same time every day (e.g., in the morning). This drug is intended for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. Patients taking a telmisartan/amlodipine combination and rosuvastatin as separate products may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before starting the telmisartan/amlodipine combination, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this drug 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, for patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: In patients 75 years of age and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin, and continue it throughout treatment. Rosuvastatin may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. Most patients are controlled with a maintenance dose of 10 mg once daily. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 mg once daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of a 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of a 40 mg dose of rosuvastatin is contraindicated in some of these patients.
This medication can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to the ingredients of this medication, a history of angioedema, severe liver or kidney disease, and those with specific heart valve diseases or muscle disorders should not take this medication. Elderly patients, individuals with hypotension, hyperkalemia, and patients with compromised liver function should use this medication with caution; in particular, they should consult healthcare professionals immediately if symptoms of muscle pain or weakness occur. This medication may have muscle-related side effects, so it is important to check muscle enzyme levels before and during treatment and monitor regularly. While taking this medication, liver function tests should also be performed periodically, and if liver enzyme levels rise significantly, the treatment should be discontinued. This medication can interact with other drugs, so patients must inform healthcare professionals about any other medications they are taking, especially when considering combinations with specific antibiotics, immunosuppressants, antihypertensive agents, and lipid-lowering drugs. Women of childbearing potential should use appropriate contraceptive methods while taking this medication, and breastfeeding mothers should either avoid this medication or discontinue breastfeeding. Safety and efficacy data are insufficient in children and adolescents under the age of 18, so it is not recommended. In case of overdose, symptoms such as hypotension, dizziness, and arrhythmias may occur, requiring immediate medical attention for appropriate treatment. This medication should be stored out of reach of children and should not be transferred to other containers.
Viral upper respiratory infection, respiratory distress, rectal bleeding, indigestion, atopic dermatitis, peripheral edema, chronic gastritis, various gastrointestinal disorders, hiatal hernia, infection, fungal infection, abscess, otitis media, angioedema, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, paresthesia, involuntary muscle contractions, sensory loss, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal illness, gout, hypercholesterolemia, diabetes, arthritis, arthralgia, leg numbness, anxiety, depression, nerve hypersensitivity, allergy, fever, leg pain, malaise, headache, dizziness, orthostatic hypotension, low back pain, headache, fatigue, nausea, abdominal pain, drowsiness, arrhythmia, bradycardia, chest pain, peripheral ischemia, syncope, postural hypotension, vasculitis, peripheral neuropathy, tremor, decreased appetite, dysphagia, pancreatitis, gingival hyperplasia, allergic reaction, burning sensation, malaise, pain, rigidity, weight gain, weight loss, arthralgia, muscle cramps, myalgia, erectile dysfunction, insomnia, abnormal dreams, depersonalization, angioedema, polymorphic erythema, pruritus, rash, erythematous rash, papulovesicular rash, visual disturbance, conjunctivitis, diplopia, ocular pain, tinnitus, ear pain, frequent urination, urination disorders, nocturia, dry mouth, increased sweating, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, headache, dizziness, constipation, nausea, abdominal pain, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, fatigue, angioedema, pruritus, hypersensitivity reaction, increased sweating, erythema, chest pain, atrial fibrillation, congestive heart failure, myocardial infarction, hypertension, worsening hypertension, hypotension, hyperkalemia, hypoglycemia, syncope, urinary tract infection, erectile dysfunction, low back pain, abdominal pain, muscle cramps, myalgia, bradycardia, eosinophilia, thrombocytopenia, increased uric acid, liver function abnormalities, liver disease, acute kidney failure, anemia, elevated CPK, anaphylactic reaction, tendon pain, hematuria, edema, gynecomastia, jaundice, elevated liver enzyme levels, leukopenia, confusion, exfoliative dermatitis, Stevens-Johnson syndrome, photosensitivity reaction, toxic epidermal necrolysis, heart failure, irregular pulse, ectopic beats, skin depigmentation, dry skin, hair loss, dermatitis, muscle weakness, single contraction, ataxia, hypertonicity, cold and clammy skin, apathy, anxiety, memory loss, gastritis, increased appetite, loose stools, rhinitis, urination disorders, polyuria, altered sense of smell, altered taste, abnormal eye accommodation, dry eye syndrome, polyneuropathy, memory loss, peripheral neuropathy, cough, respiratory distress, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnesia, memory impairment, memory dysfunction, confusion
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, so it should be stored in containers that do not allow light to enter. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius, away from extreme heat or cold.
White oval-shaped film-coated tablet
30 tablets (10 tablets x 3) / PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
DaeWon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.